Al Brockman

862 total citations
7 papers, 625 citations indexed

About

Al Brockman is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Al Brockman has authored 7 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 3 papers in Computational Theory and Mathematics and 3 papers in Pharmacology. Recurrent topics in Al Brockman's work include Malaria Research and Control (7 papers), Mosquito-borne diseases and control (4 papers) and Computational Drug Discovery Methods (3 papers). Al Brockman is often cited by papers focused on Malaria Research and Control (7 papers), Mosquito-borne diseases and control (4 papers) and Computational Drug Discovery Methods (3 papers). Al Brockman collaborates with scholars based in Thailand, United Kingdom and Australia. Al Brockman's co-authors include Nicholas J. White, François Nosten, Pratap Singhasivanon, Elizabeth A. Ashley, Robert Hutagalung, Daniel A Nash, Anne‐Catrin Uhlemann, Tim Anderson, Sanjeev Krishna and Ric N. Price and has published in prestigious journals such as Clinical Infectious Diseases, PLoS Medicine and Transactions of the Royal Society of Tropical Medicine and Hygiene.

In The Last Decade

Al Brockman

7 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Al Brockman Thailand 7 559 188 176 81 80 7 625
Lucy Phaiphun United Kingdom 9 692 1.2× 206 1.1× 154 0.9× 121 1.5× 78 1.0× 9 760
Eric M. Njunju Zambia 7 547 1.0× 133 0.7× 128 0.7× 97 1.2× 83 1.0× 10 624
Grant Dorsey United States 14 599 1.1× 193 1.0× 128 0.7× 60 0.7× 92 1.1× 19 667
Noël Rouamba Burkina Faso 15 537 1.0× 178 0.9× 120 0.7× 117 1.4× 80 1.0× 22 786
Mey Bouth Denis Cambodia 10 652 1.2× 302 1.6× 209 1.2× 44 0.5× 56 0.7× 10 713
N. M. Anstey Australia 7 497 0.9× 132 0.7× 140 0.8× 37 0.5× 57 0.7× 9 528
Daniel Blessborn Thailand 17 646 1.2× 234 1.2× 185 1.1× 94 1.2× 97 1.2× 28 882
Brioni R. Moore Australia 17 540 1.0× 144 0.8× 95 0.5× 82 1.0× 82 1.0× 56 726
Ferdinand Laihad Indonesia 14 814 1.5× 197 1.0× 169 1.0× 76 0.9× 71 0.9× 19 896
A. M. J. Oduola Nigeria 14 548 1.0× 94 0.5× 171 1.0× 80 1.0× 62 0.8× 23 689

Countries citing papers authored by Al Brockman

Since Specialization
Citations

This map shows the geographic impact of Al Brockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al Brockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al Brockman more than expected).

Fields of papers citing papers by Al Brockman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Al Brockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al Brockman. The network helps show where Al Brockman may publish in the future.

Co-authorship network of co-authors of Al Brockman

This figure shows the co-authorship network connecting the top 25 collaborators of Al Brockman. A scholar is included among the top collaborators of Al Brockman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Al Brockman. Al Brockman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ashley, Elizabeth A., Kasia Stepniewska, Niklas Lindegårdh, et al.. (2007). Pharmacokinetic study of artemether–lumefantrine given once daily for the treatment of uncomplicated multidrug‐resistant falciparum malaria. Tropical Medicine & International Health. 12(2). 201–208. 76 indexed citations
2.
Janssens, Bas, Michel Van Herp, Liesbet Goubert, et al.. (2007). A randomized open study to assess the efficacy and tolerability of dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. Tropical Medicine & International Health. 12(2). 251–259. 44 indexed citations
3.
Ashley, Elizabeth A., Kasia Stepniewska, Niklas Lindegårdh, et al.. (2007). How much fat is necessary to optimize lumefantrine oral bioavailability?. Tropical Medicine & International Health. 12(2). 195–200. 103 indexed citations
4.
Carrara, Verena I., Supakit Sirilak, Stéphane Proux, et al.. (2006). Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative. PLoS Medicine. 3(6). e183–e183. 116 indexed citations
5.
Price, Ric N., Anne‐Catrin Uhlemann, Michèle van Vugt, et al.. (2006). Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria. Clinical Infectious Diseases. 42(11). 1570–1577. 229 indexed citations
6.
Mayxay, Mayfong, Paul N. Newton, Maniphone Khanthavong, et al.. (2003). Chloroquine versus Sulfadoxine-Pyrimethamine for Treatment of Plasmodium falciparum Malaria in Savannakhet Province, Lao People's Democratic Republic: An Assessment of National Antimalarial Drug Recommendations. Clinical Infectious Diseases. 37(8). 1021–1028. 24 indexed citations
7.
Luxemburger, C., Al Brockman, K Silamut, et al.. (1998). Two patients with falciparum malaria and poor in vivo responses to artesunate. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(6). 668–669. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucy Phaiphun Breakdown of academic impact, for papers by Eric M. Njunju Breakdown of academic impact, for papers by Grant Dorsey Breakdown of academic impact, for papers by Noël Rouamba Breakdown of academic impact, for papers by Mey Bouth Denis Breakdown of academic impact, for papers by N. M. Anstey Breakdown of academic impact, for papers by Daniel Blessborn Breakdown of academic impact, for papers by Brioni R. Moore Breakdown of academic impact, for papers by Ferdinand Laihad Breakdown of academic impact, for papers by A. M. J. Oduola
Rankless by CCL
2026